List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 327 studies with search of:   "Gliosarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Recruiting Ph I Trial of Oral Topotecan + Temozolomide in Treatment of Pts w Malignant Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma
Intervention: Drug: Temodar and Topotecan
22 Active, not recruiting Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma;   Gliosarcoma;   Malignant Gliomas
Interventions: Drug: lenalidomide;   Radiation: Radiation
23 Active, not recruiting A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma;   Malignant Astrocytoma NOS
Intervention: Drug: Nanoliposomal CPT-11
24 Active, not recruiting Ph I 5-Day Temo + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temodar and O6-Benzylguanine
25 Recruiting Ph I Dasatinib + Erlotinib in Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Erlotinib and Dasatinib
26 Recruiting Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Erlotinib, Sirolimus
27 Terminated Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: erlotinib hydrochloride
28 Recruiting Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: erlotinib hydrochloride;   Drug: sorafenib tosylate;   Drug: temsirolimus;   Drug: tipifarnib
29 Active, not recruiting Radiation Therapy and Carmustine With or Without O6-Benzylguanine in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: carmustine;   Procedure: radiation therapy
30 Recruiting Bevacizumab, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Previously Treated With Radiation Therapy and Temozolomide
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bevacizumab;   Drug: erlotinib hydrochloride;   Drug: temozolomide;   Procedure: adjuvant therapy
31 Active, not recruiting 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   GBM;   Anaplastic Astrocytoma;   Oligo-Astrocytoma;   Gliosarcoma
Interventions: Drug: 131-I-TM-601;   Drug: 131I-TM601
32 Active, not recruiting Ph. I Temo + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temodar, O6-BG, and Irinotecan
33 Active, not recruiting Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
Conditions: Glioblastoma Multiforme;   Gliosarcoma
Intervention: Drug: ZD6474
34 Completed Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma
Conditions: Malignant Glioma;   Glioblastoma;   Gliosarcoma
Intervention: Drug: AP23573
35 Suspended Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Oligoastrocytoma, Mixed;   Gliosarcoma
Intervention: Gene Transfer: Interferon-beta
36 Active, not recruiting Ph. II Temo + O6-BG in Treatment of Pts w Temo-Resistant Malignant Glioma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temodar and O6-Benzylguanine
37 Active, not recruiting Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: dasatinib;   Procedure: biopsy;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: immunologic technique;   Procedure: mutation analysis
38 Recruiting Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Procedure: radiation therapy
39 Completed Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lapatinib ditosylate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
40 Suspended Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bevacizumab;   Drug: irinotecan hydrochloride;   Drug: temozolomide

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services